Business Description
Vascular Biogenics Ltd
NAICS : 325412
SIC : 2834
ISIN : IL0011327454
Total Employee Number:
7Description
Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 43.02 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -16.76 | |||||
Beneish M-Score | -3.01 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.6 | |||||
3-Year EBITDA Growth Rate | 7.1 | |||||
3-Year EPS without NRI Growth Rate | 8 | |||||
3-Year FCF Growth Rate | -4.4 | |||||
3-Year Book Growth Rate | -31.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.63 | |||||
Quick Ratio | 4.63 | |||||
Cash Ratio | 4.58 | |||||
Days Payable | 33184.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.8 | |||||
Shareholder Yield % | 12.84 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 96.47 | |||||
Operating Margin % | -3388.57 | |||||
Net Margin % | -3317.05 | |||||
EBITDA Margin % | -3225.57 | |||||
ROE % | -65.79 | |||||
ROA % | -48.86 | |||||
ROIC % | -249.99 | |||||
3-Year ROIIC % | 609.01 | |||||
ROC (Joel Greenblatt) % | -241.89 | |||||
ROCE % | -63.54 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 25.83 | |||||
PB Ratio | 0.57 | |||||
EV-to-EBIT | 0.51 | |||||
EV-to-EBITDA | 0.52 | |||||
EV-to-Revenue | -16.88 | |||||
EV-to-FCF | 0.46 | |||||
Earnings Yield (Greenblatt) % | 196.08 | |||||
FCF Yield % | -145.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vascular Biogenics Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.65 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0 - 0 | ||
| Shares Outstanding (Mil) | 77.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vascular Biogenics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vascular Biogenics Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vascular Biogenics Ltd Frequently Asked Questions
What is Vascular Biogenics Ltd(STU:0VB)'s stock price today?
The current price of STU:0VB is €0.00. The 52 week high of STU:0VB is €0.00 and 52 week low is €0.00.
When is next earnings date of Vascular Biogenics Ltd(STU:0VB)?
The next earnings date of Vascular Biogenics Ltd(STU:0VB) is .
Does Vascular Biogenics Ltd(STU:0VB) pay dividends? If so, how much?
Vascular Biogenics Ltd(STU:0VB) does not pay dividend.
Press Release
Articles on Vascular Biogenics Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers